Search Results - "Brinkhuis, Remco F."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by VAN HERWAARDEN, Antonius E, JONKER, Johan W, WAGENAAR, Els, BRINKHUIS, Remco F, SCHELLENS, Jan H. M, BEIJNEN, Jos H, SCHINKEL, Alfred H

    Published in Cancer research (Chicago, Ill.) (01-10-2003)
    “…The food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is the most abundant heterocyclic amine found in various protein containing foods…”
    Get full text
    Journal Article
  2. 2

    Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan by Jonker, Johan W., Smit, Johan W., Brinkhuis, Remco F., Maliepaard, Marc, Beijnen, Jos H., Schellens, Jan H. M., Schinkel, Alfred H.

    “…Background and Methods: Breast cancer resistance protein (BCRP/MXR/ABCP) is a multidrug-resistance protein that is a member of the adenosine…”
    Get full text
    Journal Article
  3. 3

    The mouse Bcrp1/Mxr/Abcp gene : Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin by ALLEN, J. D, BRINKHUIS, R. F, WIJNHOLDS, J, SCHINKEL, A. H

    Published in Cancer research (Chicago, Ill.) (01-09-1999)
    “…Mouse fibroblast cell lines lacking functional Mdr1a, Mdr1b, and Mrp1 genes were selected for resistance to topotecan, mitoxantrone, or doxorubicin. Each of…”
    Get full text
    Journal Article
  4. 4

    Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance by ALLEN, John D, BRINKHUIS, Remco F, VAN DEEMTER, Liesbeth, WIJNHOLDS, Jan, SCHINKEL, Alfred H

    Published in Cancer research (Chicago, Ill.) (15-10-2000)
    “…Despite accumulating evidence that multidrug resistance transporter proteins play a part in drug resistance in some clinical cancers, it remains unclear…”
    Get full text
    Journal Article